Company / Working Capital per Share
Tarsus Pharmaceuticals, Inc. Working Capital per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$10.09
FY2025
5-year range
$8.07 / $10.14
FY2021-FY2025
Trend
+25.1%
vs FY2024
Sector context
#50 of 210
Health Care
What the data says
Tarsus Pharmaceuticals, Inc.'s working capital per share of $10.09 is higher than 76% of companies in the Health Care sector (FY2025). Working Capital per Share returned to growth in FY2025 after 2 years of decline, reaching $10.09.
Based on SEC 10-K filings.
10.09 in FY2025 with a 5-year CAGR of -17.6%. Top quartile in the Health Care sector.
Improved from $8.21 to $10.09 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -0.2%
- 5-Year CAGR
- -17.6%
- 10-Year CAGR
- -
Sector benchmark
-93.1% below sector average
Key checks
Key Insights
- In FY2025, working capital per share increased 25.1% year-over-year.
- Ranks #50 out of 210 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2020.
- Lowest working capital per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score 0.92 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $10.09 | +25.1% |
| FY2024 | $8.07 | -1.7% |
| FY2023 | $8.21 | -19.1% |
| FY2022 | $10.14 | +25.3% |
| FY2021 | $8.09 | -69.6% |
| FY2020 | $26.62 | +10.0% |
| FY2019 | $24.21 | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026